NCT02450604

Brief Summary

Fabry disease is a rare inherited metabolic disorder that predominantly affects heart, kidneys and nervous system. Fabry disease has been searched in series of patients presenting different isolated signs caused by the affection of one of these organs. Acroparesthesias and chronic crises of pain of different origins are reported in the large majority of patients during the progression of the disease. Moreover, this signs are frequently inaugurating the disease. The investigators have previously performed a preliminary single-center study which permitted to identify one female patient with Fabry disease in a series of 147 consecutive patients with chronic pain tested. The investigators now propose to confirm the results of our preliminary study. The investigators plan to evaluate the prevalence of Fabry disease in a series of 1000 patients suffering from chronic pains of undetermined aetiology and consecutively recruited.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
776

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

21 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 5, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 18, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 21, 2015

Completed
6.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2021

Completed
Last Updated

August 16, 2023

Status Verified

August 1, 2023

Enrollment Period

6.8 years

First QC Date

May 18, 2015

Last Update Submit

August 11, 2023

Conditions

Keywords

Prevalence StudyFabry's diseaseChronic pain

Outcome Measures

Primary Outcomes (1)

  • Diagnosis of Fabry disease in one patient suffering from chronic pains

    J1 to 2 months after inclusion

Study Arms (1)

Patients with chronic pains of unknown aetiology

OTHER
Genetic: Diagnosis of Fabry disease

Interventions

The diagnosis of Fabry disease necessitates biochemical enzymatic measures of alphagalactosidase A activity in males, and genetic analysis using direct sequencing of GLA in females.

Patients with chronic pains of unknown aetiology

Eligibility Criteria

Age6 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • patients of both sex,
  • aged from 6 to 80,
  • with chronic pains of unknown aetiology including: acroparesthesias, and/or pain crises evolving more than 3 months, continued neuropathic evolving more than 3 months, and/or multiple pains evolving more than 3 months and/or recurrent abdominal crises of pain who come for a clinical visit in the pain Centres of France.

You may not qualify if:

  • chronic pain of known cause

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (21)

Cs douleur chronique GHSR, CHU Sud Réunion

Saint-Pierre, La Réunion, 97448, France

Location

CeRCa, Unité de Neuromyologie, CHU de Fort de France

FORT de France, Martinique, 97261, France

Location

Centre Douleurs Chroniques, CH de la Côte Basque

Bayonne, 64109, France

Location

Centre Douleurs Chroniques, CHU de Bordeaux

Bordeaux, 33076, France

Location

Service de médecine Polyvalent, CH de La Dracénie

Draguignan, 83007, France

Location

Anesthésie, Hôpital Raymond Poincaré

Garches, 92380, France

Location

Centre de la douleur de l'Adulte et de l'Enfant, CHU de Grenoble

Grenoble, 38043, France

Location

Médecine - Consultations Douleur, CH de La Réole

La Réole, 33192, France

Location

Unité Douleur et Soins Palliatifs, CH La Rochelle-Réaunis

La Rochelle, 17019, France

Location

Pole enfant - CETD Salengro, CHRU de Lille

Lille, 59037, France

Location

Pôle Anesthésie Consultation douleur, CHRU de Lille

Lille, 59037, France

Location

CETD La Timone, AP-HM

Marseille, 13385, France

Location

Centre d'Analgésie, CHRU Lapeyronie

Montpellier, 34295, France

Location

Centre d'Evaluation et de Traitement de la Douleur, CHU de Nîmes

Nîmes, 30029, France

Location

Service de Médecine de la Douleur et de Médecine Palliative, Hôpital Lariboisière-APHP

Paris, 75475, France

Location

Service de lutte contre la douleur et d'Anesthésie, CH Périgueux

Périgueux, 24 019, France

Location

Service d'Explorations Fonctionnelles et Consultations Neurologiques, CH Lyon-Sud

Pierre-Bénite, 69495, France

Location

Centre Antidouleurs, CHU de Reims

Reims, 51092, France

Location

Centre de la Douleur, CHRU de Strasbourg

Strasbourg, 67091, France

Location

Centre d'Analgésie Pédiatrique, Equipe Régionale Ressource en Soins Palliatifs-Equipe " Enfant-Do ", CHU de Toulouse

Toulouse, 31059, France

Location

Centre d'évaluation et de traitement de la Douleur, Hôpital Pierre-Paul Ricquet

Toulouse, 31059, France

Location

MeSH Terms

Conditions

Fabry DiseaseChronic Pain

Condition Hierarchy (Ancestors)

SphingolipidosesLysosomal Storage Diseases, Nervous SystemBrain Diseases, Metabolic, InbornBrain Diseases, MetabolicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCerebral Small Vessel DiseasesCerebrovascular DisordersVascular DiseasesCardiovascular DiseasesGenetic Diseases, X-LinkedGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesMetabolism, Inborn ErrorsLipidosesLipid Metabolism, Inborn ErrorsLysosomal Storage DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesLipid Metabolism DisordersPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Cyril GOIZET

    University Hospital, Bordeaux

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 18, 2015

First Posted

May 21, 2015

Study Start

March 5, 2015

Primary Completion

December 15, 2021

Study Completion

December 15, 2021

Last Updated

August 16, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations